| Patents for C07K - Peptides (3,738) |
|---|
| 09/29/2005 | US20050214859 Hepatocyte growth factor (HGF) receptor complex for identifying modulator for prevention and treatment of cell proliferative disorders |
| 09/29/2005 | US20050214748 Using severe acute respiratory syndrome (SARS) coronaviral nucleocapsid protein antigens as diagnostic indicators of respiratory disorders in humans; immunoassay |
| 09/29/2005 | US20050214738 Animal models comprising rapamycin binding (FRB) domain and target of rapamycin (TOR) sequence for use in identifying modulators of cellular pathways |
| 09/28/2005 | EP1578778A2 Ghrelin analogs |
| 09/28/2005 | EP1578764A2 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility |
| 09/27/2005 | US6949681 Intermediate for preparing glycopeptide derivatives |
| 09/22/2005 | US20050208589 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 09/22/2005 | US20050208587 Fab 4E10/KGND crystal complex for use in preparing viricidal agents; rational drug design |
| 09/22/2005 | US20050208580 Novel protein and method for producing the protein |
| 09/21/2005 | EP1575992A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 09/21/2005 | EP1575990A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 09/21/2005 | EP1575989A2 PrP sp sc /sp -INTERACTING MOLECULES AND USES THEREOF |
| 09/21/2005 | EP1575986A2 Peptides and methods for cell death regulation |
| 09/21/2005 | EP1575611A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 09/21/2005 | EP1192256B1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 09/21/2005 | CN1671420A Pegylated factor VII glycoforms |
| 09/15/2005 | WO2005040195A3 Formulation of exendins |
| 09/15/2005 | WO2005023837A3 Ebola peptides and immunogenic compositions containing same |
| 09/15/2005 | WO2005007672A3 Small molecule toll-like receptor (tlr) antagonists |
| 09/15/2005 | WO2004094461A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 09/15/2005 | WO2004016644A3 Compositions and methods used for identifying factors required for the agglomeration of proteins |
| 09/15/2005 | US20050202532 Amino acid sequences for prevention and treatment of cardiovascular disease |
| 09/14/2005 | EP1574579A2 Outer surface proteins, their genes, and their use |
| 09/14/2005 | EP1572980A2 Methods for improving secondary metabolite production in fungi |
| 09/14/2005 | EP1572723A2 Skin or hair binding peptides |
| 09/14/2005 | EP1572224A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 09/14/2005 | EP1572080A2 Fgf variants and methods for use thereof |
| 09/14/2005 | EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/14/2005 | EP1571909A2 Optimized multi-epitope constructs and uses thereof |
| 09/14/2005 | EP0833933B1 A vector and method for producing influenza hemagglutinin |
| 09/13/2005 | US6943147 Cancer treatment using proANP peptides |
| 09/09/2005 | WO2005012330A3 AMYLOID β-PEPTIDE AND METHODS OF USE |
| 09/09/2005 | WO2004101597A3 Methods for the reduction of disulfide bonds |
| 09/08/2005 | US20050197299 Peptidomimetic protease inhibitors |
| 09/07/2005 | EP1570235A2 Compositions and methods used for identifying factors required for the agglomeration of proteins |
| 09/06/2005 | US6939539 present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons |
| 09/01/2005 | WO2005079860A1 New complexes |
| 09/01/2005 | WO2005044838A3 Cd4+ epitopes of bone morphogenetic proteins |
| 09/01/2005 | WO2005035552A3 Transducing combinatorial peptide library |
| 09/01/2005 | CA2556690A1 New complexes |
| 08/31/2005 | EP1567181A2 Methods for treatment of helicobacter pylori-associated disorders |
| 08/30/2005 | US6936254 Method of inducing fetal hemoglobin synthesis |
| 08/25/2005 | WO2004043988A8 Ptprk immunogenic peptide |
| 08/24/2005 | EP1565205A2 Interferon-alpha polypeptides and conjugates |
| 08/24/2005 | EP1565203A2 Templated native silk smectic gels |
| 08/23/2005 | US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin |
| 08/18/2005 | WO2005058939A3 Methods and compositions for inhibition of bcl6 repression |
| 08/18/2005 | WO2005042559A9 Capture and release based isotope tagged peptides and methods for using the same |
| 08/18/2005 | WO2005014619A3 Heparin-binding peptides and uses thereof |
| 08/18/2005 | US20050181458 Bioassay for measuring the proliferation of T-cells in Human papiloma virus |
| 08/17/2005 | EP1564219A1 N-terminally monopegylated polypeptides and process for their preparation |
| 08/17/2005 | EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses |
| 08/17/2005 | EP0742826B1 Multivariant il-3 hematopoiesis fusion protein |
| 08/16/2005 | CA2098533C Carrier system against gnrh |
| 08/11/2005 | WO2005021580A3 Hydrogels for modulating cell migration and matrix deposition |
| 08/10/2005 | EP1560848A2 Ptprk immunogenic peptide |
| 08/10/2005 | CN1652820A Methods of treatment using CTLA-4 antibodies |
| 08/04/2005 | WO2005021579A3 Epo mimetic peptides and fusion proteins |
| 08/04/2005 | WO2005016954A3 Immunologic activity measure(s) for t “helper” on-associated conditions |
| 08/04/2005 | WO2004083234A3 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 08/04/2005 | WO2004065408A3 Enhancement of humoral immune responses using a novel myeloid accessory cell |
| 08/04/2005 | US20050171286 Copolymer-1 improvements in compositions of copolymers |
| 08/04/2005 | US20050170455 Novel prokineticin receptor isoforms and methods of use |
| 08/04/2005 | US20050170336 Using genetic engineering to prepare virus having plurality of recognition sites for selective binding or nucleating; synthesis of trifunctionalized viral particles for use as field effect transistors |
| 08/04/2005 | US20050169904 biodrug fusion protein comprising active mitochondrial protein or peptide, a mitochondrial membrane-permeant peptide and linking to a mitochondrial targeting sequence; targeting sequence is cleaved within the mitochondrial matrix, and not cleaved within the cellular cytoplasm; mitochondrial disorders |
| 07/28/2005 | WO2005044839A3 Stabilized alpha helical peptides and uses thereof |
| 07/28/2005 | WO2004087734A3 Stq-peptides |
| 07/28/2005 | WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/28/2005 | US20050163744 Novel method for down-regulation of amyloid |
| 07/27/2005 | CN1644693A Protein having tpo activity |
| 07/21/2005 | WO2005042562A3 New coupling agents for peptide synthesis |
| 07/21/2005 | WO2005026193A3 Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof |
| 07/21/2005 | WO2004094454A8 Hla-a2 tumor associated antigen peptides and compositions |
| 07/21/2005 | US20050158711 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide |
| 07/21/2005 | US20050158309 Gonadotropin-releasing hormone (gnrh); gene expression inhibition; for treatment of T-cell related neoplastic diseases |
| 07/21/2005 | US20050158301 Arg-Gly-Asp-Ala-Xaa-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val, or a C-terminal truncated fragment of the polypeptide having six or more amino acids. Xaa is alanine, glycine, serine, or an S-protected cysteine; wound healing agent, cardiac repair, bone, promote cartilage repair or growth; antirestenosis |
| 07/20/2005 | EP1554377A2 Thermostable reverse transcriptases and uses thereof |
| 07/20/2005 | EP1553976A2 Hiv envelope-cd4 complexes and hybrids |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1211123C Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 07/14/2005 | WO2005049636A3 Method of analyzing protein |
| 07/14/2005 | WO2005021583A3 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β |
| 07/14/2005 | WO2005007675A3 TRIAZOLE ϵ-AMINO ACIDS |
| 07/14/2005 | WO2005000871A3 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 07/14/2005 | WO2004094453A3 Filtration of dipeptide and dipeptide derivative sweeteners |
| 07/14/2005 | US20050153945 Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof |
| 07/14/2005 | US20050152907 Used to diagnose and treat various diseases, including human cancers associated with expression and/or over-expression of KID3 |
| 07/13/2005 | CN1210290C Delivery of nucleic acids |
| 07/07/2005 | WO2005061535A1 Novel antimicrobial peptides with heparin binding activity |
| 07/07/2005 | WO2005040193A3 Synthetic peptides that cause f-actin bundling and block actin depolymerization |
| 07/07/2005 | WO2005014617A3 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 07/07/2005 | WO2004046167A3 Synthesis and self-assembly of abc triblock bola peptide |
| 07/07/2005 | WO2004034957A3 Methods for treatment of helicobacter pylori-associated disorders |
| 07/07/2005 | WO2004022579A3 Cellular delivery of natriuretic peptides |
| 07/07/2005 | US20050148511 Fibroblast growth factor (FGF); enhanced receptor subtype specificity and/or affinity; for treatment of skeletal dysplasia, osteoporosis and enhancing bone fracture healing and cartilage healing processes; mitogens |
| 07/07/2005 | US20050148038 Biomimetic chemotaxis receptor-signal complex for use in identifying modulators of B-cell and T-cell receptor signaling pathways; immunotherapy |
| 07/07/2005 | US20050147587 Protein fusion comprising colony stimulating factor activity for use as tool in rapid stimulation and production of white blood cells and neutrophils |
| 07/07/2005 | CA2523998A1 Novel antimicrobial peptides |
| 06/30/2005 | WO2005058941A2 Aβ IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME |
| 06/30/2005 | WO2005058940A2 Immunogenic peptide carrier conjugates and methods of producing same |